PEG化タンパク質治療薬の世界市場：市場規模・現状・予測

• 英文タイトル：Global PEGylated Protein Therapeutics Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST03971
• 出版社/出版日：QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

※当調査レポートでは、PEG化タンパク質治療薬の世界市場について調査・分析し、PEG化タンパク質治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（コロニー刺激因子、インターフェロン、エリスロポエチン（EPO）、組換え第VIII因子、モノクローナル抗体、酵素、その他）、用途別（癌、自己免疫疾患、肝炎、多発性硬化症、血友病、胃腸障害、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。

・レポートの概要
・世界のPEG化タンパク質治療薬市場動向
・主要企業別マーケットシェア
・PEG化タンパク質治療薬の種類別市場規模2014-2019
（コロニー刺激因子、インターフェロン、エリスロポエチン（EPO）、組換え第VIII因子、モノクローナル抗体、酵素、その他）
・PEG化タンパク質治療薬の用途別市場規模2014-2019
（癌、自己免疫疾患、肝炎、多発性硬化症、血友病、胃腸障害、その他）
・PEG化タンパク質治療薬の北米市場：主要企業・種類別/用途別市場規模
・PEG化タンパク質治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模
・PEG化タンパク質治療薬の中国市場：主要企業・種類別/用途別市場規模
・PEG化タンパク質治療薬の日本国内市場：主要企業・種類別/用途別市場規模
・PEG化タンパク質治療薬の東南アジア市場：主要企業・種類別/用途別市場規模
・PEG化タンパク質治療薬のインド市場：主要企業・種類別/用途別市場規模
・PEG化タンパク質治療薬の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Merck、Pfizer、UCB、Amgen、AstraZeneca、Biogen、Roche、Horizon Pharma、Leadiant Biosciences）
・PEG化タンパク質治療薬の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...

PEGylation is the process of covalent and non-covalent attachment of polyethylene glycol polymer chains to molecules, such as a drug, therapeutic protein, or vesicle. PEGylated protein therapeutics is estimated to show significant market growth during the forecast period, majorly due to the, growth in demand for PEGylation, rise in number of chronic diseases, and presence of strong pipeline drugs.Higher process cost associated with PEGylation and patent expiry of certain drugs are projected to hinder the market growth.
In 2018, the global PEGylated Protein Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global PEGylated Protein Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the PEGylated Protein Therapeutics development in United States, Europe and China.

The key players covered in this study
Merck
Pfizer
UCB
Amgen
AstraZeneca
Biogen
Roche
Horizon Pharma
Leadiant Biosciences

Market segment by Type, the product can be split into
Colony Stimulating Factor
Interferon
Erythropoietin (EPO)
Recombinant Factor VIII
Monoclonal Antibody
Enzyme
Others

Market segment by Application, split into
Cancer
Autoimmune Disease
Hepatitis
Multiple Sclerosis
Hemophilia
Gastrointestinal Disorder
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global PEGylated Protein Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the PEGylated Protein Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of PEGylated Protein Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global PEGylated Protein Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Colony Stimulating Factor
1.4.3 Interferon
1.4.4 Erythropoietin (EPO)
1.4.5 Recombinant Factor VIII
1.4.6 Monoclonal Antibody
1.4.7 Enzyme
1.4.8 Others
1.5 Market by Application
1.5.1 Global PEGylated Protein Therapeutics Market Share by Application (2014-2025)
1.5.2 Cancer
1.5.3 Autoimmune Disease
1.5.4 Hepatitis
1.5.5 Multiple Sclerosis
1.5.6 Hemophilia
1.5.7 Gastrointestinal Disorder
1.5.8 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 PEGylated Protein Therapeutics Market Size
2.2 PEGylated Protein Therapeutics Growth Trends by Regions
2.2.1 PEGylated Protein Therapeutics Market Size by Regions (2014-2025)
2.2.2 PEGylated Protein Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 PEGylated Protein Therapeutics Market Size by Manufacturers
3.1.1 Global PEGylated Protein Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global PEGylated Protein Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global PEGylated Protein Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 PEGylated Protein Therapeutics Key Players Head office and Area Served
3.3 Key Players PEGylated Protein Therapeutics Product/Solution/Service
3.4 Date of Enter into PEGylated Protein Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global PEGylated Protein Therapeutics Market Size by Type (2014-2019)
4.2 Global PEGylated Protein Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States PEGylated Protein Therapeutics Market Size (2014-2019)
5.2 PEGylated Protein Therapeutics Key Players in United States
5.3 United States PEGylated Protein Therapeutics Market Size by Type
5.4 United States PEGylated Protein Therapeutics Market Size by Application

6 Europe
6.1 Europe PEGylated Protein Therapeutics Market Size (2014-2019)
6.2 PEGylated Protein Therapeutics Key Players in Europe
6.3 Europe PEGylated Protein Therapeutics Market Size by Type
6.4 Europe PEGylated Protein Therapeutics Market Size by Application

7 China
7.1 China PEGylated Protein Therapeutics Market Size (2014-2019)
7.2 PEGylated Protein Therapeutics Key Players in China
7.3 China PEGylated Protein Therapeutics Market Size by Type
7.4 China PEGylated Protein Therapeutics Market Size by Application

8 Japan
8.1 Japan PEGylated Protein Therapeutics Market Size (2014-2019)
8.2 PEGylated Protein Therapeutics Key Players in Japan
8.3 Japan PEGylated Protein Therapeutics Market Size by Type
8.4 Japan PEGylated Protein Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia PEGylated Protein Therapeutics Market Size (2014-2019)
9.2 PEGylated Protein Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia PEGylated Protein Therapeutics Market Size by Type
9.4 Southeast Asia PEGylated Protein Therapeutics Market Size by Application

10 India
10.1 India PEGylated Protein Therapeutics Market Size (2014-2019)
10.2 PEGylated Protein Therapeutics Key Players in India
10.3 India PEGylated Protein Therapeutics Market Size by Type
10.4 India PEGylated Protein Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America PEGylated Protein Therapeutics Market Size (2014-2019)
11.2 PEGylated Protein Therapeutics Key Players in Central & South America
11.3 Central & South America PEGylated Protein Therapeutics Market Size by Type
11.4 Central & South America PEGylated Protein Therapeutics Market Size by Application

12 International Players Profiles
12.1 Merck
12.1.1 Merck Company Details
12.1.2 Company Description and Business Overview
12.1.3 PEGylated Protein Therapeutics Introduction
12.1.4 Merck Revenue in PEGylated Protein Therapeutics Business (2014-2019)
12.1.5 Merck Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 PEGylated Protein Therapeutics Introduction
12.2.4 Pfizer Revenue in PEGylated Protein Therapeutics Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 UCB
12.3.1 UCB Company Details
12.3.2 Company Description and Business Overview
12.3.3 PEGylated Protein Therapeutics Introduction
12.3.4 UCB Revenue in PEGylated Protein Therapeutics Business (2014-2019)
12.3.5 UCB Recent Development
12.4 Amgen
12.4.1 Amgen Company Details
12.4.2 Company Description and Business Overview
12.4.3 PEGylated Protein Therapeutics Introduction
12.4.4 Amgen Revenue in PEGylated Protein Therapeutics Business (2014-2019)
12.4.5 Amgen Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Company Details
12.5.2 Company Description and Business Overview
12.5.3 PEGylated Protein Therapeutics Introduction
12.5.4 AstraZeneca Revenue in PEGylated Protein Therapeutics Business (2014-2019)
12.5.5 AstraZeneca Recent Development
12.6 Biogen
12.6.1 Biogen Company Details
12.6.2 Company Description and Business Overview
12.6.3 PEGylated Protein Therapeutics Introduction
12.6.4 Biogen Revenue in PEGylated Protein Therapeutics Business (2014-2019)
12.6.5 Biogen Recent Development
12.7 Roche
12.7.1 Roche Company Details
12.7.2 Company Description and Business Overview
12.7.3 PEGylated Protein Therapeutics Introduction
12.7.4 Roche Revenue in PEGylated Protein Therapeutics Business (2014-2019)
12.7.5 Roche Recent Development
12.8 Horizon Pharma
12.8.1 Horizon Pharma Company Details
12.8.2 Company Description and Business Overview
12.8.3 PEGylated Protein Therapeutics Introduction
12.8.4 Horizon Pharma Revenue in PEGylated Protein Therapeutics Business (2014-2019)
12.8.5 Horizon Pharma Recent Development
12.9 Leadiant Biosciences
12.9.1 Leadiant Biosciences Company Details
12.9.2 Company Description and Business Overview
12.9.3 PEGylated Protein Therapeutics Introduction
12.9.4 Leadiant Biosciences Revenue in PEGylated Protein Therapeutics Business (2014-2019)
12.9.5 Leadiant Biosciences Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table PEGylated Protein Therapeutics Key Market Segments
Table Key Players PEGylated Protein Therapeutics Covered
Table Global PEGylated Protein Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global PEGylated Protein Therapeutics Market Size Market Share by Type 2014-2025
Figure Colony Stimulating Factor Figures
Table Key Players of Colony Stimulating Factor
Figure Interferon Figures
Table Key Players of Interferon
Figure Erythropoietin (EPO) Figures
Table Key Players of Erythropoietin (EPO)
Figure Recombinant Factor VIII Figures
Table Key Players of Recombinant Factor VIII
Figure Monoclonal Antibody Figures
Table Key Players of Monoclonal Antibody
Figure Enzyme Figures
Table Key Players of Enzyme
Figure Others Figures
Table Key Players of Others
Table Global PEGylated Protein Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Cancer Case Studies
Figure Autoimmune Disease Case Studies
Figure Hepatitis Case Studies
Figure Multiple Sclerosis Case Studies
Figure Hemophilia Case Studies
Figure Gastrointestinal Disorder Case Studies
Figure Others Case Studies
Figure PEGylated Protein Therapeutics Report Years Considered
Table Global PEGylated Protein Therapeutics Market Size 2014-2025 (Million US$)
Figure Global PEGylated Protein Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global PEGylated Protein Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global PEGylated Protein Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global PEGylated Protein Therapeutics Market Share by Regions 2014-2019
Figure Global PEGylated Protein Therapeutics Market Share by Regions 2014-2019
Figure Global PEGylated Protein Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global PEGylated Protein Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global PEGylated Protein Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global PEGylated Protein Therapeutics Market Share by Manufacturers in 2018
Table Global PEGylated Protein Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players PEGylated Protein Therapeutics Product/Solution/Service
Table Date of Enter into PEGylated Protein Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global PEGylated Protein Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global PEGylated Protein Therapeutics Market Size Share by Type (2014-2019)
Figure Global PEGylated Protein Therapeutics Market Size Market Share by Type (2014-2019)
Table Global PEGylated Protein Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global PEGylated Protein Therapeutics Market Size Share by Application (2014-2019)
Figure Global PEGylated Protein Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global PEGylated Protein Therapeutics Revenue Market Share by Application in 2018
Figure United States PEGylated Protein Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players PEGylated Protein Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players PEGylated Protein Therapeutics Market Share (2018-2019)
Table United States PEGylated Protein Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States PEGylated Protein Therapeutics Market Share by Type (2014-2019)
Table United States PEGylated Protein Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States PEGylated Protein Therapeutics Market Share by Application (2014-2019)
Figure Europe PEGylated Protein Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players PEGylated Protein Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players PEGylated Protein Therapeutics Market Share (2018-2019)
Table Europe PEGylated Protein Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe PEGylated Protein Therapeutics Market Share by Type (2014-2019)
Table Europe PEGylated Protein Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe PEGylated Protein Therapeutics Market Share by Application (2014-2019)
Figure China PEGylated Protein Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players PEGylated Protein Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players PEGylated Protein Therapeutics Market Share (2018-2019)
Table China PEGylated Protein Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China PEGylated Protein Therapeutics Market Share by Type (2014-2019)
Table China PEGylated Protein Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China PEGylated Protein Therapeutics Market Share by Application (2014-2019)
Figure Japan PEGylated Protein Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players PEGylated Protein Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players PEGylated Protein Therapeutics Market Share (2018-2019)
Table Japan PEGylated Protein Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan PEGylated Protein Therapeutics Market Share by Type (2014-2019)
Table Japan PEGylated Protein Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan PEGylated Protein Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia PEGylated Protein Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players PEGylated Protein Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players PEGylated Protein Therapeutics Market Share (2018-2019)
Table Southeast Asia PEGylated Protein Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia PEGylated Protein Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia PEGylated Protein Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia PEGylated Protein Therapeutics Market Share by Application (2014-2019)
Figure India PEGylated Protein Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players PEGylated Protein Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players PEGylated Protein Therapeutics Market Share (2018-2019)
Table India PEGylated Protein Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India PEGylated Protein Therapeutics Market Share by Type (2014-2019)
Table India PEGylated Protein Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India PEGylated Protein Therapeutics Market Share by Application (2014-2019)
Figure Central & South America PEGylated Protein Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players PEGylated Protein Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players PEGylated Protein Therapeutics Market Share (2018-2019)
Table Central & South America PEGylated Protein Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America PEGylated Protein Therapeutics Market Share by Type (2014-2019)
Table Central & South America PEGylated Protein Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America PEGylated Protein Therapeutics Market Share by Application (2014-2019)
Table Merck Company Details
Table Merck Revenue in PEGylated Protein Therapeutics Business (2014-2019) (Million US$)
Figure Merck Revenue Growth Rate in PEGylated Protein Therapeutics Business (2014-2019)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in PEGylated Protein Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in PEGylated Protein Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table UCB Company Details
Table UCB Revenue in PEGylated Protein Therapeutics Business (2014-2019)(Million US$)
Figure UCB Revenue Growth Rate in PEGylated Protein Therapeutics Business (2014-2019)
Table UCB Recent Development
Table Amgen Company Details
Table Amgen Revenue in PEGylated Protein Therapeutics Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in PEGylated Protein Therapeutics Business (2014-2019)
Table Amgen Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in PEGylated Protein Therapeutics Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in PEGylated Protein Therapeutics Business (2014-2019)
Table AstraZeneca Recent Development
Table Biogen Company Details
Table Biogen Revenue in PEGylated Protein Therapeutics Business (2014-2019)(Million US$)
Figure Biogen Revenue Growth Rate in PEGylated Protein Therapeutics Business (2014-2019)
Table Biogen Recent Development
Table Roche Company Details
Table Roche Revenue in PEGylated Protein Therapeutics Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in PEGylated Protein Therapeutics Business (2014-2019)
Table Roche Recent Development
Table Horizon Pharma Company Details
Table Horizon Pharma Revenue in PEGylated Protein Therapeutics Business (2014-2019)(Million US$)
Figure Horizon Pharma Revenue Growth Rate in PEGylated Protein Therapeutics Business (2014-2019)
Table Horizon Pharma Recent Development
Table Leadiant Biosciences Company Details
Table Leadiant Biosciences Revenue in PEGylated Protein Therapeutics Business (2014-2019)(Million US$)
Figure Leadiant Biosciences Revenue Growth Rate in PEGylated Protein Therapeutics Business (2014-2019)
Table Leadiant Biosciences Recent Development
Table Global PEGylated Protein Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global PEGylated Protein Therapeutics Market Size Share by Regions (2019-2025)
Figure Global PEGylated Protein Therapeutics Market Size Share by Regions in 2025
Figure United States PEGylated Protein Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe PEGylated Protein Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China PEGylated Protein Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan PEGylated Protein Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia PEGylated Protein Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India PEGylated Protein Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America PEGylated Protein Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global PEGylated Protein Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global PEGylated Protein Therapeutics Market Size by Product (2019-2025)
Figure Global PEGylated Protein Therapeutics Market Size by Product in 2025
Table Global PEGylated Protein Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global PEGylated Protein Therapeutics Market Size by Application (2019-2025)
Figure Global PEGylated Protein Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界の組換え血漿タンパク質治療薬市場：専門的調査

Global Recombinant Plasma Protein Therapeutics Market Professional Survey Report 2019
QYR9ST09333 2019年9月5日 108Pages
※本調査レポートは、組換え血漿タンパク質治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、組換え凝固因子、ヒトC1エステラーゼ阻害剤に、用途別には、血友病...

生物学的治療法の世界市場：市場規模・現状・予測

Global Biologic Therapeutics Market Size, Status and Forecast 2019-2025
QYR9ST04721 2019年9月2日 96Pages
※当調査レポートでは、生物学的治療法の世界市場について調査・分析し、生物学的治療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ワクチン、血液製剤、アレルギー性エキス、ヒト細胞および組織、遺伝子治...

C反応性タンパク質試験の世界市場：市場規模・現状・予測

Global C-Reactive Protein Testing Market Size, Status and Forecast 2019-2025
QYR9ST04782 2019年9月2日 94Pages
※当調査レポートでは、C反応性タンパク質試験の世界市場について調査・分析し、C反応性タンパク質試験の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ELISA、免疫比濁法、化学発光イムノアッセイ（CL...

Fc融合タンパク質の世界市場：市場規模・現状・予測

Global Fc Fusion Protein Market Size, Status and Forecast 2019-2025
QYR9ST04839 2019年9月2日 96Pages
※当調査レポートでは、Fc融合タンパク質の世界市場について調査・分析し、Fc融合タンパク質の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（in vitro、免疫組織化学、フローサイトメトリー、結合ア...

プロテイン結晶化の世界市場：市場規模・現状・予測

Global Protein Crystallization Market Size, Status and Forecast 2019-2025
QYR9ST05011 2019年9月2日 92Pages
※当調査レポートでは、プロテイン結晶化の世界市場について調査・分析し、プロテイン結晶化の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（蒸気拡散法、ハイスループット法）、用途別（バイオテクノロジー、医...

プロテイン結晶化の世界市場：市場規模・現状・予測

プロテイン薬品の世界市場：市場規模・現状・予測

Global Protein Drugs Market Size, Status and Forecast 2019-2025
QYR9ST05012 2019年9月2日 97Pages
※当調査レポートでは、プロテイン薬品の世界市場について調査・分析し、プロテイン薬品の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗体薬、ペプチドホルモン、血液製剤、酵素）、用途別（病院、診療所、そ...

血漿タンパク質結合アッセイの世界市場：市場規模・現状・予測

Global Plasma Protein Binding Assay Market Size, Status and Forecast 2019-2025
QYR9ST03974 2019年9月2日 93Pages
※当調査レポートでは、血漿タンパク質結合アッセイの世界市場について調査・分析し、血漿タンパク質結合アッセイの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（平衡透析、限外濾過、超遠心分離、ゲル濾過クロ...

プロテイン薬品の世界市場：市場規模・現状・予測

ヒト胎盤タンパク質の世界市場：市場規模・現状・予測

Global Human Placental Protein Market Size, Status and Forecast 2019-2025
QYR9ST03914 2019年9月2日 99Pages
※当調査レポートでは、ヒト胎盤タンパク質の世界市場について調査・分析し、ヒト胎盤タンパク質の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（加水分解済ヒト胎盤タンパク質、その他）、用途別（ライフサイエ...

第VIII因子欠乏症の治療の世界市場：市場規模・現状・予測 Factor VIII is an essential blood-clotting protein, which is also known as an antihemophilic factor. In individuals, factor VIII is encoded by F8 gene. Defects in F8 gene lead to hemophilia A, a recessive X-linked coagulation disorder. Factor VIII is generated in liver sinusoidal cells and endotheli…
血友病A及びB組換え因子補充療法の世界市場：市場規模・現状・予測 Haemophilia is a group of inherited genetic disorders which causes abnormal or exaggerated bleeding. It impairs the normal mechanism of blood clotting after an injury. Internal bleeding inside the joint or inside brain is commonly seen in the patients with severe to moderate haemophilia. Its symptom…
世界の組換え血漿タンパク質治療薬市場：専門的調査 Recombinant plasma protein therapeutics market is driven by various factors such as shift from use of plasma-derived proteins to recombinant therapies, rise in awareness about rare disease management and increased focus on investments in rare diseases.Rising demand from Asia-Pacific region is a majo…
モノクローナル抗体治療薬の世界市場：インサイト・予測 For transferring the insulin a device is used that is known as insulin patch pump. Owing to the presence of the adhesive, the insulin patch pump gets directly attached to the body. The presence of the adhesive avoids the requirement of the infusion set and tubing for attaching the pump to the body.T…
モノクローナル抗体カスタムサービスの世界市場：市場規模・現状・予測 Monoclonal antibodies are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal ant…